The World Health Summit, organised by the M8 Alliance of Academic Health Centers, Universities and National Academies, brings together experts from academia, industry, politics and civil society and aims to improve health all over the planet, catalyzing that process through collaboration and open dialogue, and steering tomorrow’s agenda to improve research, education, healthcare, and policy outcomes. The event is held under the continuous patronage of the Chancellor of Germany, the President of France, as well as the President of the European Commission.
In her keynote speech, Jayasree will present the Antimicrobial Resistance Benchmark, the first independent assessment of how pharmaceutical companies are tackling the rise of antimicrobial resistance (AMR). It found that some companies are active on many fronts, including antibiotic research & development and AMR surveillance, while others are taking smaller steps.
The Access to Medicine Foundation has started the methodology review for the next Antimicrobial Resistance Benchmark – by consulting a wide range of experts and stakeholders to refine its analysis of pharmaceutical company responses to antimicrobial resistance. The new Antimicrobial Resistance Benchmark will be published in early 2020.